Antigenic Essence: Upgrade of Cellular Cancer Vaccines
The development of anticancer immunotherapy is characterized by several approaches, the most recognized of which include cellular vaccines, tumor-associated antigens (TAAs), neoantigens, and chimeric antigen receptor T cells (CAR-T). This paper presents antigenic essence technology as an effective m...
Main Authors: | Petr G. Lokhov, Elena E. Balashova |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/4/774 |
Similar Items
-
Changing Landscape of Cancer Vaccines—Novel Proteomics Platform for New Antigen Compositions
by: Balashova, E.E, et al.
Published: (2022) -
Changing Landscape of Cancer Vaccines—Novel Proteomics Platform for New Antigen Compositions
by: Balashova, E.E, et al.
Published: (2022) -
SANTAVAC<sup>TM</sup>: Summary of Research and Development
by: Petr G. Lokhov, et al.
Published: (2019-11-01) -
From genomes to vaccines via the proteome
by: R Alan Wilson, et al.
Published: (2004-08-01) -
Proteomics, Bioinformatics and Structure-Function Antigen Mining For Gonorrhea Vaccines
by: Benjamin I. Baarda, et al.
Published: (2018-12-01)